Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial

BACKGROUND: The optimal sequence of adjuvant chemotherapy and radiotherapy for breast cancer is unknown. SECRAB assesses whether local control can be improved without increased toxicity. METHODS: SECRAB was a prospective, open-label, multi-centre, phase III trial comparing synchronous to sequential...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernando, Indrajit N., Bowden, Sarah J., Herring, Kathryn, Brookes, Cassandra L., Ahmed, Ikhlaaq, Marshall, Andrea, Grieve, Robert, Churn, Mark, Spooner, David, Latief, Talaat N., Agrawal, Rajiv K., Brunt, Adrian M., Stevens, Andrea, Goodman, Andrew, Canney, Peter, Bishop, Jill, Ritchie, Diana, Dunn, Janet, Poole, Christopher J., Rea, Daniel W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Scientific Publishers 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005671/
https://www.ncbi.nlm.nih.gov/pubmed/31785830
http://dx.doi.org/10.1016/j.radonc.2019.10.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005671/
https://www.ncbi.nlm.nih.gov/pubmed/31785830
http://dx.doi.org/10.1016/j.radonc.2019.10.014

Ejemplares similares